FASEB Welcomes Three New Member Societies

December 17, 2015
The nation’s largest coalition of biological and biomedical organizations is pleased to announce the addition of three new member societies. On January 1, 2016, the Society for Experimental Biology and Medicine (SEBM), American Aging Association (AGE), and US Human Proteome Organization (US HUPO) join the Federation of American Societies for Experimental Biology (FASEB), bringing the Federation’s membership to 30 organizations. 

“FASEB’s new member societies represent scientists and physicians who perform cutting-edge research in critically important scientific domains,” said FASEB President Parker B. Antin, PhD. “We welcome their unique perspectives to the Federation and look forward to their active participation in addressing the issues affecting the biological and biomedical sciences.”

SEBM promotes investigation in the biomedical sciences by encouraging and facilitating interchange of scientific information among disciplines. “SEBM is pleased to supplement our membership benefits with the advocacy work and strong public affairs presence that FASEB affords,” said SEBM President Warren Zimmer, PhD. “We believe our scientists and physician-scientists will enrich the perspectives of the FASEB community.” 

AGE serves biomedical scientists dedicated to understanding the basic mechanisms of aging and the development of interventions in age-related disease to increase healthy lifespan. “Joining FASEB gives AGE members the opportunity to interact and collaborate with experts from a variety of scientific disciplines,” said AGE Chairman and Chief Executive Officer, Janko Nikolich- Žugich, MD, PhD. “We look to FASEB to help advance AGE’s public affairs goals, including advocating for increased research support and communicating research advances to Capitol Hill.” 

Proteomics is the study of an organism’s full complement of proteins. US HUPO engages in scientific and educational activities to encourage the use of proteomics technologies and to disseminate proteomics knowledge broadly. “FASEB’s advocacy is a benefit to the scientific community at large to insure that all manner of scientific research is funded and that its importance is known to legislative representatives that make decisions that impact both scientific education and research in the United States,” said Joshua LaBaer, MD, PhD, US HUPO President. “FASEB membership will help broaden the reach of US HUPO, whereas the field of proteomics bridges the broad interests of many FASEB member societies.”

Categories: FASEB General Announcements; FASEB Member Societies; Science Policy & Advocacy;